Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo

Carlton L. Schwab, Diana P. English, Dana M. Roque, Stefania Bellone, Salvatore Lopez, Emiliano Cocco, Roberta Nicoletti, Thomas J. Rutherford, Peter E. Schwartz, Alessandro D. Santin

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences